Australia-listed shares of AVITA Medical slump on forecast cut

AVITA Medical

08/01/2025 04:34

* ASX-listed shares of AVITA Medical  AVH.AX   RCEL.O  fall
as much as 20.2% to A$3.470
  
        ** Stock last down about 18.8%, set for deepest one-day
decline since Oct 2023
  
    ** Regenerative medicine firm cuts forecast for the fourth
time in five quarters
    ** Says it expects Q4 commercial revenue of about $18.4 mln,
compared to its prior guidance range of $22.3 mln to $24.3 mln
    ** Stock hits lowest price level since mid-Nov
    ** About 2 mln shares change hands, highest since mid-Aug
2022
    ** Stock fell 0.9% in 2024    

 (Reporting by Jasmeen Ara Shaikh in Bengaluru)
 ((Jasmeenaraislam.shaikh@thomsonreuters.com))